FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
May 31, 2024 Comments Off
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender